Preclinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma
Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-P13
Published Online: 2015-11-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Drent, Esther
Groen, Richard
Noort, Willy
van Bueren, Jeroen Lammerts
Parren, Paul
Kuball, Jürgen
Sebestyen, Zsolt
van de Donk, Niels
Martens, Anton
Lokhorst, Henk
Mutis, Tuna
Article History
First Online: 4 November 2015